Features How It Works Privacy Ingredients Support
Download on the App Store Get it on Google Play

Tocopheryl Acetate — The Vitamin E Ester, Not Tocopherol

On 13 November 2026 our catalogue included about 26,000 products with at least one variant whose ingredient list names Tocopheryl Acetate. It is the acetic acid ester of tocopherol, used as an antioxidant and a skin-conditioning agent. The CIR conclusion is in the safety section. Tocopherol is a different INCI: the free form, with the phenol that the acetate blocks.

Data sources: Fiume and colleagues, “Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics,” International Journal of Toxicology 2018;37(2_suppl):61S–94S (the published CIR final amended report; panel meeting 18 March 2014, release 4 April 2014); the 2002 CIR final report cited there (Andersen, ed., Int J Toxicol. 2002;21(Suppl 3):51–116); SCCNFP/0494/01, opinion on alpha-tocopherol acetate, adopted 25 September 2001; Baschong and colleagues, J Cosmet Sci. 2001;52(3):155–161, as summarised in the CIR report’s Table 6; de Groot and colleagues, Contact Dermatitis 1991;25(5):302–304; Warshaw and colleagues, Dermatitis 2021 (NACDG, 2001–2016); EU CosIng ref. 38627, read on 13 November 2026; ECHA substance pages for CAS 7695-91-2 and CAS 58-95-7, and PubChem CID 2117 GHS section, read 13 November 2026 at 11:23 UTC. Japanese and Korean names follow JCIA and KCID. Catalogue figures were read on 13 November 2026. Last updated: November 2026.

At a Glance

INCI Name
Tocopheryl Acetate
Also Known As
3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-yl acetate; vitamin E acetate
CAS Number
7695-91-2. CosIng also lists 58-95-7.
EC Number
231-710-0 / 200-405-4
Formula
C31H52O3. The acetic acid ester of tocopherol. Molecular weight 472.7.
Catalogue functions
Antioxidant, skin conditioning
Other names
酢酸トコフェロール (JCIA); 토코페릴아세테이트 (KCID); 生育酚乙酸酯
Catalogue count
About 26,000 products in our catalogue on 13 November 2026. A product is counted once if any variant names Tocopheryl Acetate.

What Is Tocopheryl Acetate?

Tocopheryl acetate (INCI: Tocopheryl Acetate, CAS 7695-91-2, EC 231-710-0 / 200-405-4) is the ester formed when acetic acid is attached to the phenol of tocopherol. The catalogue lists the functions antioxidant and skin conditioning, and the formula C31H52O3. Those function labels describe a role in a formula. They are not a claim that the ingredient treats a named skin disease. This page is about topical cosmetic use.


It is not tocopherol. Tocopherol is the free form: the phenol is open. Tocopheryl acetate is that phenol acetylated. The names are not substitutes on a label. A product that lists Tocopherol does not, by that name, contain Tocopheryl Acetate, and the reverse is also true. Searches for one often land on the other because both are sold as vitamin E.


The acetate is the more storage-stable of the two. The SCCNFP opinion of 25 September 2001 says the native compound, alpha-tocopherol, has limited stability at room temperature, which is why the esters are used in sunscreen and skin-care products. Acetylation also blocks the phenol, so the ester does not do the same radical-scavenging job as free tocopherol until some of it is converted back.


Conversion in skin happens, and it is limited and depends on the vehicle. The 2014 CIR report summarises Baschong and colleagues (Journal of Cosmetic Science, 2001) in Table 6, an ex vivo study on viable human skin. In this ex vivo study, approximately 35–51% of the recovered vitamin E material in the underlying skin was present as free tocopherol, depending on the vehicle and application conditions. This percentage does not represent conversion of the total applied dose. Non-occlusive application favoured greater deposition in the underlying skin, whereas occlusion generally increased the proportion converted within that layer. In a triglyceride oil, the ester almost entirely remained as the ester, on the surface and in the horny layer. That is one ex vivo study. It is not a percentage for every cream on the market. A mouse-skin experiment summarised in the same report found hydrolysis under 1% of the applied dose in that protocol. The two results are not the same experiment.


The 2014 CIR report describes manufacture this way: tocopherol is isolated on a commercial scale from vegetable oils, and it is also produced synthetically, in which case a racemic mixture of eight stereoisomers is formed. Tocopheryl acetate is prepared by esterifying tocopherol with acetic acid. CosIng lists two CAS numbers for this INCI. CAS 58-95-7, EC 200-405-4, is RRR-alpha-tocopheryl acetate. CAS 7695-91-2, EC 231-710-0, is all-rac-alpha-tocopheryl acetate. RRR-alpha-tocopheryl acetate is commonly associated with natural-source vitamin E, whereas all-rac-alpha-tocopheryl acetate is commonly produced synthetically. The INCI name alone does not establish stereoisomer composition or raw-material provenance.

What Does Tocopheryl Acetate Do in a Formula?

🧪

The ester

It is tocopherol with an acetate on the phenol. That is why the INCI is Tocopheryl Acetate and not Tocopherol. The ester is a different ingredient.

🛡️

Antioxidant, as a function label

The catalogue and CosIng list an antioxidant function. The acetate is chosen because it keeps better than free tocopherol. It is not the free phenol. The acetate lacks the free phenolic group needed for tocopherol's direct radical-scavenging activity. Its potential antioxidant contribution in skin depends partly on conversion to free tocopherol, which varies with the vehicle and application conditions. An INCI function listing does not establish the clinical benefit of a finished product.

🧴

Skin conditioning

The catalogue lists skin conditioning. That is a label for how a formula is meant to leave the skin feeling. The amount in a given product is not on the INCI list.

Where it shows up: on 13 November 2026, among about 26,000 products in our catalogue, it appears in moisturisers, serums, sunscreens, cleansers, face masks, body lotions, shampoos, eye care, lipsticks, and nail products. The cards below use the full product name and the kind of product that name describes.

Tocopheryl Acetate vs Tocopherol

Tocopheryl acetate and tocopherol are compared here on the molecule, the label, and what skin does with the ester. Many searches for one open the page for the other.

Tocopheryl acetateTocopherol
What it isThe acetic acid ester of tocopherol. C31H52O3. The phenol is acetylated.The free form. The phenol is open. Several tocopherols share the INCI Tocopherol. The tocopherol page is the page for that name.
On a labelThe INCI name is Tocopheryl Acetate. 生育酚乙酸酯. Vitamin E acetate is a common English name, not a second INCI.The INCI name is Tocopherol. A list that says Tocopherol is not, by that word, listing the acetate.
Stability and the skinMore storage-stable than free tocopherol. Skin esterases convert some of it back. In an oil, most of the recovered material was still the acetate, on the surface and in the horny layer.The free phenol is the form that scavenges radicals without waiting for hydrolysis. It is also the less storage-stable form, which is why many formulas use the ester.

Regulatory status

The EU CosIng entry for Tocopheryl Acetate, ref. 38627, was checked against the current official entry on 13 November 2026. The functions listed are antioxidant and skin conditioning. A CosIng listing names functions. It is not an approval, and it is not evidence about safety.


On 13 November 2026 the current entry showed no annex reference linked. That is what the entry displayed on that date. It is not a claim that no sentence in an annex could ever touch a raw material sold under this name. The SCCNFP opinion of 2001 said alpha-tocopherol and its derivatives were not, at that time, subject to a particular rule in the annexes of Directive 76/768/EEC, and use fell under the general requirement that a product must not cause damage to health. That is the committee’s statement about the directive then in force. It is not a fresh reading of every annex line in 2026.

Is Tocopheryl Acetate Safe?

1 / 10

Our hazard-signal rating

The CIR conclusion and this rating are different things. The CIR text conclusion is set out in the card below. The SCCNFP opinion of 2001 is a separate text conclusion.

The number in the circle is this site’s hazard-signal rating. Tocopheryl Acetate is on a fixed list of familiar ingredients with a set value; for listed names that value takes precedence, hazard codes are not read and no restriction add-on applies. The number is not calculated from the toxicology studies, case reports, patch-test data, or H413 cited on this page. There is no scientific basis on this page for treating 1 versus 2, or any other exact value, as meaningful. Readers should rely on the CIR and SCCNFP conclusions and on the allergy and environmental sections, which are presented independently. It is a rule-based classification. It is not a percentage of risk, and it is not a judgement on any single product. How our hazard-signal rating works.

What this page is drawing on
CIR — 2014 final amended report, published 2018
✓ Safe in the present practices of use and concentration

Fiume and colleagues (International Journal of Toxicology, 2018) is the published form of the CIR final amended report released on 4 April 2014. The conclusion covers 14 tocopherols and tocotrienols, tocopheryl acetate among them: safe in the present practices of use and concentration described in that assessment. The earlier final report, from 2002, had already reached that conclusion for tocopheryl acetate. The 2014 report is the re-review, and it is the current CIR conclusion. The wording is a text conclusion. It is not a numeric level, and it is not this site’s hazard-signal rating.

Table 4 is the scope. FDA VCRP data for 2014 give 9,677 uses, of which 9,098 are reported as tocopheryl acetate and 579 as tocopheryl acetate dl-alpha. A 2013 industry survey gives a concentration range of 0.00000001–36%. The leave-on maximum of 36% is the nail figure: nail products were reported at 0.002–36%. Dermal contact was reported at 0.000045–5%. Rinse-off was reported up to 10%. Eye-area products were reported up to 4.9%. Baby products were reported at 0.001–0.1%. Those figures are category survey values, not the percentage in a reader’s product, and not a legal limit. They are also not our catalogue’s about 26,000 products.

The Panel said irritation and sensitisation data available since the 2002 review indicate that tocopheryl acetate is not an irritant or a sensitiser, and that the irritation and sensitisation potentials of this ingredient group were not of concern. That sentence sits next to published case reports, which are set out below. The Panel’s conclusion is what it said after the data it reviewed. It is not a finding that no person has ever reacted.

CIR says it is funded by the Personal Care Products Council, and that CIR, the Expert Panel for Cosmetic Ingredient Safety, and the review process are independent from the Council and the cosmetics industry. The US FDA describes CIR as an industry-funded panel of scientific and medical experts. The FDA says it participates in CIR meetings but does not vote, that it may agree or disagree with CIR conclusions, and that it takes CIR reviews into consideration when it evaluates cosmetic ingredient safety.

SCCNFP — 2001 opinion
✓ No restriction proposed, on the knowledge then

SCCNFP/0494/01, adopted on 25 September 2001, is the opinion of the EU scientific committee that preceded the SCCS. The committee was asked whether the documented profile supported a statement that alpha-tocopherol acetate poses a significant threat to the consumer, and whether it proposed any restrictions. The question was prompted by a mouse study in which the acetate, applied in acetone, did not prevent photocarcinogenesis and was reported as possibly enhancing tumours. The committee said the biological relevance of that animal experiment for human health was questionable because of experimental shortcomings, and that other toxicological data did not support those animal findings. Its opinion was that, on the knowledge then available, alpha-tocopherol acetate does not pose a threat to the health of the consumer, and it proposed no restrictions or conditions of use.

That opinion does not set a cosmetic concentration. It is not an SCCS opinion, and this page did not find a later SCCS opinion that replaces it or that sets a limit for this ingredient. The CIR table above is the later account of surveyed cosmetic concentrations.

Irritation, contact sensitisation, immediate hypersensitivity
✓ Three different events

Irritation, becoming sensitised and then reacting on contact, and immediate hypersensitivity are different events. A positive patch test is a test result. It is not, by itself, the same thing as a clinical reaction the patient is having, and the studies below judge relevance separately when they judge it at all. This page does not rank exposure routes. The data below are about skin contact.

The CIR report’s reading of the irritation and sensitisation studies is the sentence in the CIR card: the data indicated that tocopheryl acetate is not an irritant or a sensitiser, and the Panel did not treat the potential as a concern for cosmetic use at the surveyed concentrations. Case reports still exist. de Groot and colleagues (Contact Dermatitis, 1991) reported four patients with cosmetic allergy and positive patch tests to tocopheryl acetate. Those are case reports, not a rate. The test concentration is under Further reading.

Warshaw and colleagues (Dermatitis, 2021) reviewed North American Contact Dermatitis Group tests from 2001 to 2016. The paper was published after the 2014 CIR assessment and was not part of the data CIR reviewed. Of 38,699 patients tested with dl-alpha-tocopherol 100% and/or dl-alpha-tocopherol acetate 100%, 349 reacted, 0.9%. Of those positive reactions, 87.6% were judged currently clinically relevant, and 51.4% were weak. The authors describe positive reactions as relatively rare given how widely these ingredients are used. The 0.9% is a frequency in patch-tested dermatitis patients, not a rate for people in general, and the series does not split the free form from the acetate. The tocopherol page is where the free-form screening cycles are set out. A positive patch test in that series is not a result about immediate hypersensitivity.

The 1990s outbreak that the 2002 CIR report discussed was traced to tocopheryl linoleate, a different ester, not to tocopheryl acetate. Mixing the two esters is how that outbreak gets misread as an acetate finding.

GHS — supplier notified
H413 in ECHA C&L notifications
An aquatic statement, not a skin statement

H413 is reported in ECHA C&L notifications for one listed identity. The CLP wording is “may cause long lasting harmful effects to aquatic life.” That environmental hazard is a separate question from skin safety. Article 1(5) of Regulation (EC) No 1272/2008 provides that CLP hazard classification does not apply to finished cosmetics intended for the final user.

Things to Know

Use levels in the 2014 table: The 2013 concentration-of-use bands are in the CIR card above, including nail products, dermal contact, rinse-off, the eye area, and baby products. They are unpublished data submitted for the CIR assessment. They are not the percentage in a reader’s jar, and not a legal cap. The 2014 reaffirmation points at those practices of use, not at an unlimited concentration.

Further reading: In the clinical test the CIR report cites, a cuticle softener containing 36% tocopheryl acetate was essentially non-irritating in a single-insult occlusive patch test in 19 subjects. Undiluted dl-alpha-tocopheryl acetate was reported as not a sensitiser in a human study summarised from an ECHA robust summary. Those concentrations belong to those tests. They are not a licence to read every product as 36%, and they are not the dermal-contact maximum in the 2013 survey. de Groot and colleagues patch tested tocopheryl acetate at 10% in petrolatum in the four cases from 1991. The NACDG materials in the 2001–2016 series were undiluted dl-alpha-tocopherol and/or undiluted dl-alpha-tocopherol acetate. Undiluted test material is not the concentration in a moisturiser. PubChem CID 2117 is dl-alpha-tocopheryl acetate. The GHS section, read on 13 November 2026 at 11:23 UTC, shows two separate ECHA notification sets, and this page does not add them together. For EC 231-710-0, PubChem gives 1,939 reports from 5 notifications: 1,849 of 1,939 do not meet GHS hazard criteria, and 90 of 1,939, from one notification, include hazard codes that PubChem does not name, because it only displays codes above 10%. For a different EC number, 692-041-1, PubChem gives 11 reports from 1 notification and names H413. Notifications for different CAS or EC identities are not pooled into one percentage. Those shares of notifications are not a probability of harm from using a product. This page does not treat the unnamed codes in the 90 reports as H413.

Other uses: Oral vitamin E supplements, and food use of alpha-tocopheryl acetate as a nutrient, are outside this page. The CIR report set oral supplement epidemiology aside for cosmetic use because it expected systemic exposure from cosmetics to be lower than from supplements, and it called that epidemiology inconclusive. That is not a pregnancy finding. Separately, vitamin E acetate in lung fluid was associated with e-cigarette, or vaping, product use-associated lung injury (Blount and colleagues, New England Journal of Medicine, 2020). That association is about inhalation, not about a cream or a serum left on the skin.

Pregnancy & Nursing

The 2014 CIR report and the 2001 SCCNFP opinion do not tell people to avoid cosmetic tocopheryl acetate in pregnancy or while breastfeeding, and they do not set a cosmetic concentration just for pregnancy or breastfeeding. Not advising avoidance is not a pregnancy-specific assessment. The sources cited on this page are not enough to quantify risk from cosmetic use during pregnancy or breastfeeding. This page does not estimate that risk from a cream, a sunscreen, or a serum. Someone who is pregnant or breastfeeding and wants advice about a specific product should ask their own clinician.

Information on this page is for education and is not medical advice. On 13 November 2026 our catalogue included about 26,000 products with at least one variant that names Tocopheryl Acetate. The 2018 publication of the 2014 CIR report, the 2001 SCCNFP opinion, and the studies cited above are the sources for the safety conclusion, the use counts, and the concentrations. The hazard-signal rating in the rating section is a rule-based classification, not a percentage of risk. Last updated: November 2026.

How to Read It on a Label

Look for the INCI name Tocopheryl Acetate. Tocopherol is the other ingredient. Labels may also show vitamin E acetate, acetato de tocoferilo, 生育酚乙酸酯, 醋酸生育酚, 酢酸トコフェロール, or 토코페릴아세테이트. The Japanese name follows JCIA, and the Korean name follows KCID. Under Regulation (EC) No 1223/2009, Article 19(1)(g), ingredients are listed in descending order of weight when they are added, and ingredients below 1% may be listed in any order after the ones at or above 1%. A position near the end does not reveal the percentage. The INCI name alone does not establish stereoisomer composition or raw-material provenance.

Selected products in the catalogue

On 13 November 2026 our catalogue included about 26,000 products with at least one variant whose ingredient list names Tocopheryl Acetate. A product is counted once. The count is a usage figure for this catalogue, not evidence of safety. The cards are a selection. Each card uses the full product name and the kind of product that name describes.

Frequently Asked Questions

What is tocopheryl acetate?
Tocopheryl acetate is the INCI name for the acetic acid ester of tocopherol, C31H52O3. CosIng lists CAS 7695-91-2 and CAS 58-95-7. In cosmetics it is listed as an antioxidant and a skin-conditioning agent. It is not the INCI Tocopherol. It is not established as a treatment for a specific skin condition.
Is tocopheryl acetate safe?
The CIR conclusion, set out in the safety section, is that tocopheryl acetate is safe in the practices of use and concentration described in the 2014 assessment. The surveyed uses and concentrations are in that section. That conclusion is about the surveyed uses and the formulations that were studied. How a finished product feels still depends on the whole formula and on the person. Case reports of allergic contact dermatitis are in the safety section. Our hazard-signal rating.
What is the difference between tocopherol and tocopheryl acetate?
Tocopherol is the free form. Tocopheryl acetate is the acetate ester: more storage-stable, and converted back to tocopherol in the skin only in part, and more so in some vehicles than in an oil. They are different INCI names. Tocopherol.
Is tocopheryl acetate the same as vitamin E?
Vitamin E acetate is a common name for this ester. Vitamin E is also used for free tocopherol and for the tocotrienols. On a cosmetic label the INCI decides which one is present. Tocopheryl Acetate is the ester. Tocopherol is the free form.
Can tocopheryl acetate cause a skin allergy?
Irritation, contact sensitisation, and immediate hypersensitivity are different. The CIR report’s reading of the studies was that tocopheryl acetate was not an irritant or a sensitiser in the tests it relied on. Case reports of allergic contact dermatitis still exist, including four patients reported by de Groot and colleagues in 1991 with positive patch tests. The 2001–2016 NACDG series was published in 2021, after the 2014 CIR assessment, and was not part of the data CIR reviewed. It tested the free form and the acetate together, so its 0.9% figure is not an acetate-only rate, and it is a figure for patch-tested dermatitis patients. A positive patch test is not a result about immediate hypersensitivity. The safety section has the numbers and the test concentrations.
Is tocopheryl acetate something to avoid in pregnancy?
The 2014 CIR report and the 2001 SCCNFP opinion do not advise against cosmetic tocopheryl acetate in pregnancy or while breastfeeding, and they do not give a pregnancy-only concentration. Not advising avoidance is not a pregnancy-specific assessment, and those sources are not enough to quantify risk from cosmetic use during pregnancy or breastfeeding. This page does not estimate a personal risk. A clinician who knows the pregnancy or the breastfeeding is the right person to ask about a specific product.

Related Ingredients

Tocopherol

The free form of vitamin E, and a different INCI. The comparison table is above.

Ascorbic Acid

Another antioxidant that often appears on the same lists. This page does not claim that the two protect each other in a finished product.

Niacinamide

Listed for skin conditioning, and a common companion on serum and moisturiser lists. Sharing a list is not a finding that the pair suits every person.

Squalane

An emollient often listed beside vitamin E.

Check a product’s full ingredient list

SkinSenseDiary reads the ingredient list on products in the catalogue, including the difference between tocopheryl acetate and tocopherol.

Download on the App StoreGet it on Google Play